PUBLIC COMPANY
saveShanghai Henlius Biotech Inc
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 8- tagOncology9 co-mentions · 3 sources
- tagApproval6 co-mentions · 3 sources
- tagBreast Cancer5 co-mentions · 1 sources
- drugBILPREVDA4 co-mentions · 2 sources
- tagNSCLC3 co-mentions · 2 sources
- tagPulmonology2 co-mentions · 2 sources
- drugpertuzumab biosimilar2 co-mentions · 1 sources
- drugdenosumab2 co-mentions · 2 sources
pipeline
8
marketed
1
phase 3
3
catalysts ytd
3
approvals ytd
0
recalls ytd
0
Pipeline(8)
pipeline depth8 products
3Phase 31Marketed3Unknown1pre_registration
Marketed
BILPREVDA
Phase 3HLX-43
Squamous Non-Small Cell Lung Cancer
Phase 3dulpatatug
Adenocarcinoma Of The Gastroesophageal Junction
Phase 3serplulimab
Small-Cell Lung Cancer
Programmed cell death protein 1
drugHLX-35
drugHLX-3901
drugPOHERDY
pre_registrationbevacizumab biosimilar
Cervical Cancer
Vascular endothelial growth factor A, long form
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that